comparemela.com

Latest Breaking News On - Blue owl healthcare opportunities - Page 1 : comparemela.com

Context Therapeutics Announces $100 Million Private Placement

Financing includes new and existing leading healthcare investors

Philadelphia
Pennsylvania
United-states
Gina-mangiaracina
Piper-sandler
Jennifer-minai-azary
Exchange-commission
Great-point-partners
Nextech-invest-ltd
Company-nasdaq
Context-therapeutics-inc
Nasdaq

Form 8-K Korro Bio, Inc. For: Apr 17

Form 8-K Korro Bio, Inc. For: Apr 17
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Washington
United-states
Delaware
Cambridge
Cambridgeshire
United-kingdom
Rock-springs
Piper-sandler
Ram-aiyar
Kendall-square
Korro-bio-inc
Atlas-venture

Korro Bio (KRRO) Announces $70M Placement

Korro Bio (KRRO) Announces $70M Placement
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Piper-sandler
Atlas-venture
Korro-bio-inc
Korro-bio
Deep-track-capital
Blue-owl-healthcare-opportunities
Rock-springs-capital
Tri-locum-partners
Securities-act

TORL secures $158m for oncology pipeline development

Clinical-stage biotechnology company TORL BioTherapeutics has announced the closure of an oversubscribed $158m Series B-2 financing round.

Mark-alles
Bristol-myers-squibb
Perceptive-xontogeny-venture-fund
Deep-track-capital
Perceptive-advisors
Goldman-sachs-alternatives
Moore-strategic-ventures
Vertex-ventures
Blue-owl-healthcare-opportunities
Avidity-partners

TORL BioTherapeutics Announces $158 Million Oversubscribed Series B-2 Financing to Advance the Clinical Development of its Novel Antibody-Drug Conjugate (ADC) Oncology Pipeline

$158M Series B-2 Financing led by Deep Track Capital, with new participation from leading global biotechnology investors including RA Capital Management,.

Dave-licata
Vince-ruiz
Ribociclib-kisqali
Mark-alles
Palbociclib-ibrance
Dennis-slamon
Perceptive-xontogeny-venture-fund
Slamon-research-laboratory
Bristol-myers-squibb
Division-of-hematology-oncology
Roth-zabel
Crandon-law

vimarsana © 2020. All Rights Reserved.